Morgan Stanley has launched Ethereum and Solana trust products that intend to include staking rewards, and each one carries a 0.14% expense ratio. The fee is clear. The “Americas Cheapest” claim is not verified by the material available.
- Products: Morgan Stanley Ethereum Trust (MSSE) and Morgan Stanley Solana Trust (MSOL)
- Fee: 0.14% expense ratio each
- Staking: Both trusts intend to stake part of their holdings and may earn rewards
- Structure: Morgan Stanley describes them as ETPs/trusts, not standard 40 Act ETFs
- Caution: “Americas Cheapest” is a marketing claim, not a confirmed market-wide comparison
That makes this a meaningful step for crypto access through mainstream finance. It also serves as a good reminder that the label on a product can be slicker than the plumbing underneath it. Trusts, ETPs, ETFs, these words get tossed around like they mean the same thing. They do not.
According to Morgan Stanley, the new products are the Morgan Stanley Ethereum Trust and Morgan Stanley Solana Trust, listed on NYSE Arca under the tickers MSSE and MSOL. The firm says both are designed to track ether and SOL, respectively, while intending to stake a portion of their holdings. Morgan Stanley also says it will not retain any portion of the staking rewards for itself.
That staking piece is where the products get interesting. Staking means committing crypto to help secure a proof-of-stake network and, in return, earning rewards. Ethereum and Solana both run on proof-of-stake systems, so staking is part of how those networks work. In plain English: the network pays participants for helping keep the system running. Not quite a money printer, more like getting paid to guard the door while the casino is still open.
But staking is not free yield. It comes with trade-offs. There can be validator risk, operational risk, lockup or exit delays, and slashing penalties if something goes wrong with the staking setup. That matters even more inside a packaged investment product, because investors are not just taking on the price volatility of ETH or SOL. They are also taking on the structure and mechanics of the wrapper around them.
The 0.14% expense ratio is the clearest hard number in the launch. It is low by traditional finance standards, and that will appeal to anyone comparing crypto products on cost. But low cost is not the same thing as “cheapest in the Americas, ” which is the part of the headline that needs skepticism. The available details do not provide a regional comparison against other ETH or SOL products in the United States, Canada, Brazil, or anywhere else in the hemisphere.
In other words: 0.14% is a documented fee. “Cheapest in the Americas” is still just a claim unless someone puts the full comparison table on the page.
It also matters that Morgan Stanley calls these products trusts and exchange-traded products, not ordinary ETFs under the Investment Company Act of 1940. That is not a minor legal footnote. It affects how the products are regulated, what risks investors face, and how closely they resemble the kind of ETF most people picture when they hear the term.
The distinction is worth keeping straight because crypto marketing loves a semantic blur. If a product sounds like an ETF, trades like an ETF, and gets described in headlines like an ETF, plenty of readers will assume it is one. But legal structure matters. It determines everything from oversight to custody to the way staking is handled behind the curtain.
That said, the bigger signal here is hard to miss. Morgan Stanley is not just dabbling in Bitcoin exposure anymore. It is expanding into Ethereum and Solana, which suggests the firm sees digital assets as a broader investment category rather than a one-coin curiosity. That is a real shift in how Wall Street packages crypto: not as a novelty, but as a line item for portfolios.
There is also a practical reason Ethereum and Solana fit this kind of product. Bitcoin is the cleanest monetary asset in crypto for many investors, the hard-money, proof-of-work benchmark. Ethereum and Solana are different animals, programmable networks with staking mechanics and yield-like features. That makes them more natural candidates for products that try to pass through staking rewards. It also means they come with more moving parts, which is exactly where finance likes to dress complexity up as convenience.
For a deeper look at the mechanics behind those network choices, Morgan Stanley has separate explainers on staking fundamentals and Solana fundamentals, both of which help show why these assets are being packaged differently from Bitcoin.
Morgan Stanley’s own risk disclosures are blunt. Digital assets are volatile, and shares could lose all or substantially all of their value. These trusts may also trade at a premium or discount to net asset value, which means the market price can drift away from the value of the underlying holdings. Add staking-specific risks, custody issues, and the fact that these products are relatively new, and the “simple access” pitch starts looking less simple.
That does not make the launch meaningless. Far from it. Mainstream, regulated access matters. So does lower stated pricing. So does the fact that a major institution is willing to build products around proof-of-stake assets, not just Bitcoin. For investors who want exposure without self-custody, wallets, seed phrases, or the usual parade of user-error disasters, that convenience has real value.
Still, convenience is not the same thing as safety, and yield is not the same thing as free money. The smart takeaway is not “Wall Street has blessed crypto, therefore all is well.” The smart takeaway is that institutions are increasingly comfortable packaging ETH and SOL into familiar investment wrappers, but the burden remains on investors to understand exactly what they’re buying.
For background on the company’s broader push into digital assets, see Morgan Stanley’s Bold Crypto Move and its separate coverage of the Solana Trust Filing. The firm’s crypto playbook is not just one product launch; it is a pattern.
That pattern also lines up with the firm’s broader expansion into lending against digital assets, including its work on Bitcoin-backed loans through Galaxy Digital. Different product, same message: the old guard is finding more ways to make crypto feel like a normal balance-sheet line item.
On the regulatory side, the underlying filing reflects the same familiar tension between innovation and paperwork. The SEC filing itself, while dry enough to cure insomnia, is still where the real mechanics live: custody, staking, fees, and how the product is actually structured. For the source document, see the SEC filing.
And yes, there is also a straight-up press release from the firm describing the launch of the Ethereum and Solana trusts. Corporate press releases are, naturally, written in the polished language of “look at us, we did a thing, ” so a healthy dose of skepticism is still required.
Key questions and takeaways
-
What did Morgan Stanley launch?
Morgan Stanley launched the Morgan Stanley Ethereum Trust (MSSE) and the Morgan Stanley Solana Trust (MSOL), both exchange-traded digital asset products tied to ether and SOL. -
Do the products include staking rewards?
Yes. Morgan Stanley says both trusts intend to stake a portion of their holdings and may receive staking rewards, while the firm will not retain any portion of those rewards for itself. -
How much do they cost?
Morgan Stanley says each product has an expense ratio of 0.14%. That is the clearest confirmed pricing detail available. -
Are these standard ETFs?
Not based on the available details. Morgan Stanley describes them as trusts and exchange-traded products, not ordinary 1940 Act ETFs. -
Is “Americas Cheapest” confirmed?
No. The available material supports the 0.14% fee, but it does not provide a regional fee comparison to prove the products are the cheapest across the Americas. -
What is the biggest risk?
Investors face crypto price volatility, plus product-structure risk and staking risks such as slashing, operational problems, custody issues, and possible premiums or discounts to net asset value.
Morgan Stanley’s move is a sign that proof-of-stake assets are getting more comfortable seats at the grown-up table of finance. That is progress. Just don’t confuse a low-fee wrapper with a low-risk bet.
